Human CMV vaccine trials: What if CMV caused a rash?

Journal of Clinical Virology

Volumn 41, Issue 3, 2008, Pages 231-236

  Adler, Stuart P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytomegalovirus; Pregnancy; Vaccine trials; Vaccines

Indexed keywords

CYTOMEGALOVIRUS VACCINE; GLYCOPROTEIN B; LIVE VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; TOWNE VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; FEASIBILITY STUDY; HUMAN; IMMUNIZATION; INFANT DISEASE; PRIORITY JOURNAL; RASH; SINGLE DRUG DOSE; TODDLER;

ADULT; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; EXANTHEMA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; RESEARCH DESIGN;

EID: 39149109307     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.11.008     Document Type: Article

References (35)

1. Adler S.P. Congential cytomegalovirus screening. Pediatr Infect Dis J 24 (2005) 1105-1106
2. Adler S.P., Starr S.E., Plotkin S.A., Hempfling S.H., Buis J., Manning M.L., et al. Immunity induced by a primary cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 171 (1995) 26-32
3. Adler S.P., Hempfling S.H., Starr S.E., Plotkin S.A., and Riddle S. Evaluation of the safety and immunogenicity of the Towne strain of cytomegalovirus among women of childbearing age and children. Pediatr Infect Dis J 17 (1998) 200-206
4. Adler S.P., Finney J.W., Manganello A.M., and Best A.M. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis J 15 (1996) 240-246
5. Adler S.P., Finney J.W., Manganello A.M., and Best A.M. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 145 (2004) 485-491
6. Balfour Jr. H.H., Welo P.K., and Sachs G.W. Cytomegalovirus vaccine trial in 400 renal transplant candidates. Trans Proc 17 (1985) 81-83
7. Bia F.J., Miller S.A., Lucia H.L., Griffith B.P., Tarsio M., and Hsiung G.D. Vaccination against transplacental cytomegalovirus transmission: vaccine reactivation and efficacy in guinea pigs. J Infect Dis 149 (1984) 355-362
8. Bia F.J., Griffith B.P., Tariso M., and Hsiung G.D. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus. J Infect Dis 142 (1980) 732-738
9. Bratcher D.F., Bourne N., Bravo F.J., et al. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis 172 (1995) 944-950
10. Chatterjee A., Harrison C.J., Britt W.J., and Bewtra C. Modification of maternal and congenital cytomegalovirus infection anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis 183 (2001) 547-553
11. Chen S.F., Tu W.W., Sharp M.A., Tongson C.E., He X.S., Greenberg H.S., et al. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J Infect Dis 189 (2004) 1619-1627
12. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed. (1981), Wiley, New York
13. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., and Alford C.A. The outcome of congenital CMV infection in relation to maternal antibody status. N Engl J Med 326 (1992) 663-667
14. Fowler K.B., Stagno S., and Pass R.F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289 (2003) 1008-1011
15. Fowler K.B., and Pass R.F. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics 118 (2006) 286-292
16. Frey S.E., Harrison C., Pass R.F., Yang E., Boken D., Sekulovich R.E., et al. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein b subunit vaccine. J Infect Dis 180 (1999) 1700-1703
17. Jacobson M.A., Sinclair E., Bredt B., Agrillo L., Black D., Epling C.L., et al. Cytomegalovirus (CMV) Antigen-specific CD4+ and CD8+ T cell proliferation and IFN gamma responses in CMV-seronegative Recipients of Towne CMV Vaccine. J Clin Virol 35 (2006) 332-337
18. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143 (2003) 16-25
19. Mitchell D.K., Holmes S.J., Burke R.L., Duliege M., and Adler S.P. Immunogenicity of a recombinant human cytomegalovirus (CMV) gB vaccine in seronegative toddlers. Pediatr Infect Dis J 21 (2002) 133-138
20. Morton C.C., and Nance W.E. Newborn hearing screening-a silent revolution. N Engl J Med 18 (2006) 2151-2164
21. Nigro G., Adler S.P., La Torre R., and Best A.M. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353 (2005) 1350-1356
22. Pass R.F., Duliege A.M., Boppana S., Sekulovich R., Percell S., Britt W., et al. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein b and a new adjuvant. J Infect Dis 180 (1999) 970-975
23. Plotkin S.A., Starr S.E., Friedman H.M., Gonczol E., and Weibel R.E. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis 159 5 (1989) 860-865
24. Plotkin S.A., Starr S.E., Friedman H.M., Brayman K., et al. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. Ann Intern Med 114 (1991) 525-531
25. Plotkin S.A., Higgins R., Kurtz J.B., Morris P.J., Cambell D.A., Shope T.C., et al. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation 58 (1994) 1176-1178
26. Plotkin S.A., and Huang E.-S. Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J Infect Dis 152 (1985) 395-397
27. Ross S.A., Fowler K.B., Ashrith G., Stagno S., Britt W.J., Pass R.F., et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 148 (2006) 332-336
28. Schleiss M.R., Bourne N., Stroup G., Bravo F.J., Jensen N.J., and Bernstein D.I. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis 189 (2004) 1374-1381
29. Schleiss M.R. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus. J Clin Virol 2 (2002) S37-S49
30. Schleiss M.R., Lacayo J.C., Belkaid Y., McGregor A., Stroup G., Rayner J., et al. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis 195 (2007) 789-798
31. Stagno S. Cytomegalovirus. In: Remington J.S., and Klein J.O. (Eds). Infectious diseases of the fetus and newborn infant. 4th ed. (2001), WB Saunders, Philadelphia 389-424
32. Stagno S., Pass R.F., Cloud G., Britt W.J., et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256 (1986) 1904-1908
33. Stratton K., Durch J., and Lawrence R. Vaccines for the 21st century: a tool for decisionmaking vol. 1 (2001), National Academy Press, Washington, DC p. 476
34. Tu W., Chen S., Sharp M., Dekker C., Manganello A.M., Tongson C.E., et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 172 (2004) 3260-3267
35. Wang J.B., Adler S.P., Hempfling S., Burke R.L., Duliège A.M., Starr S.E., et al. Mucosal antibodies to CMV glycoprotein B occur following both natural infection and immunization with human cytomegaloviral vaccines. J Infect Dis 174 (1996) 397-492